Powering drug development with advanced AI retrosynthetic analysis tools

Powering drug development with advanced AI retrosynthetic analysis tools

Brought to you by Lonza Small Molecules

Overview

As small molecule APIs become increasingly complex, longer synthetic pathways present new challenges for process chemists. Drug developers are turning to evolving tools to find reliable and efficient synthesis routes to produce small molecule APIs. This white paper outlines the advanced retrosynthetic analysis services offered by Lonza’s Small Molecules division and how these tools empower better, more efficient development of innovative small molecule drugs.

Key Objectives:

Evolving challenges in small molecule API synthesis
Principles of retrosynthetic analysis and its value in drugmaking
How advanced retrosynthetic analysis tools enable more sophisticated and efficient drug development

Brought to you by:

Please complete the form to download the white paper.

Forwarded this link? Clear the form

Email Address*

Salutation*

First Name*

Last Name*

Company*

Job Title*

Address 1*

City*

State*

Zip / Post Code*

Country/Territory/Area*

Business Phone*

Are you currently working on a small molecule drug development project?*

Would you like to learn more about Lonza’s early de-risking services?*

I would like to receive C&EN’s weekly newsletter with the latest in chemistry news

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.